G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,392 | -42.2% | 967 | 0.0% | 0.00% | – |
Q2 2023 | $2,407 | -99.3% | 967 | -97.9% | 0.00% | – |
Q1 2022 | $358,000 | -25.6% | 47,109 | -0.0% | 0.00% | -100.0% |
Q4 2021 | $481,000 | -23.9% | 47,125 | +0.1% | 0.00% | 0.0% |
Q3 2021 | $632,000 | -37.4% | 47,060 | +2.3% | 0.00% | 0.0% |
Q2 2021 | $1,009,000 | -15.2% | 45,982 | -7.1% | 0.00% | -50.0% |
Q1 2021 | $1,190,000 | +22.9% | 49,478 | -8.1% | 0.00% | +100.0% |
Q4 2020 | $968,000 | +74.1% | 53,835 | +11.9% | 0.00% | 0.0% |
Q3 2020 | $556,000 | -58.1% | 48,117 | -12.1% | 0.00% | -50.0% |
Q2 2020 | $1,328,000 | +152.5% | 54,759 | +14.8% | 0.00% | +100.0% |
Q1 2020 | $526,000 | -56.3% | 47,716 | +4.8% | 0.00% | -50.0% |
Q4 2019 | $1,203,000 | +15.2% | 45,524 | -0.7% | 0.00% | 0.0% |
Q3 2019 | $1,044,000 | -22.7% | 45,839 | +4.0% | 0.00% | -33.3% |
Q2 2019 | $1,351,000 | +172.9% | 44,056 | +47.8% | 0.00% | +200.0% |
Q1 2019 | $495,000 | -8.5% | 29,815 | +5.6% | 0.00% | 0.0% |
Q4 2018 | $541,000 | -44.0% | 28,246 | +52.9% | 0.00% | -50.0% |
Q3 2018 | $966,000 | +13.9% | 18,474 | -5.3% | 0.00% | 0.0% |
Q2 2018 | $848,000 | +94.9% | 19,502 | +66.3% | 0.00% | +100.0% |
Q1 2018 | $435,000 | – | 11,730 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
RA Capital Management | 363,051 | $6,027,000 | 0.26% |
BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |